0
Politics
Shot in the arm for GSK and AstraZeneca from cancer drug sales
April 29, 2026
Scroll
Posted 1 hour ago by
The blue chip drug makers saw first quarter earnings beat market expectations.
The Standard
Coverage and analysis from United Kingdom. All insights are generated by our AI narrative analysis engine.
United Kingdom
Bias: lean right
People's Voices (0)
Leave a comment
0/500
Note: Comments are moderated. Please keep it civil. Max 3 comments per day.